Association Between Frailty and Adverse In-hospital Outcomes after Head and Neck Cancer Surgery Among US Older Adults

K. Siwakoti,S. Dahal,G.R. Williams,S. Giri

DOI: https://doi.org/10.1016/j.ijrobp.2024.01.127

IF: 8.013

2024-04-01

International Journal of Radiation Oncology*Biology*Physics

Abstract:Purpose/Objective(s) Nearly half of patients diagnosed with head and neck cancers are 65 years or older at the time of diagnosis. While surgery remains an important curative modality, older adults with cancer are at increased risk of immediate post-operative complications. Emerging studies indicate the role of pre-operative frailty assessment in predicting adverse outcomes after cancer therapy. The objective of this study was to study the association between frailty and in-hospital complications in a cohort of older adults undergoing head and neck cancer surgery. Materials/Methods Using discharge level data from the National Inpatient Sample (NIS), we identified a cohort of older adults (≥65y) who underwent an ablative procedure for a malignant oral cavity, oropharyngeal, hypopharyngeal or laryngeal neoplasm at US community hospitals in 2020. Frailty was defined using diagnosis codes corresponding to the Johns Hopkins Adjusted Clinical Groups frailty indicator. Multivariable regression was used to study the impact of frailty on in-hospital mortality, length of stay non-home discharge and cost of hospitalization, taking into account the complex survey design of NIS. Results A total of 3586 (weighted 17,929) US hospitalizations were identified among older adults (≥65y) undergoing head and neck cancer surgery. The overall mean age was 74y±6 years, with 60% males and 78% non-hispanic Whites. The overall in-hospital mortality was low (0.8%), with a median length of stay of 3 days (Interquartile range, IQR 1-8 days). Overall 36% had discharge disposition other than home and the median hospital charge was $80872 (IQR 46443-157127). Overall, 10.4% patients were identified to be frail. In multivariable models, frailty was associated with a significantly increased risk of adverse outcomes including higher in-hospital mortality (Odds Ratio, OR 4.95; 95% CI 2.01-12.18, p value <0.01), longer hospitalization days (β 6.76; 95% CI 5.21-8.32; p value <0.01), non-home discharge (OR 4.50; 95%CI 3.40-5.95; p value <0.01) and increased cost of hospitalization (β 88670; 95% CI 65523-112917; p value <0.01). Conclusion Frailty assessment prior to head and neck cancer surgery may help identify patients at risk of adverse outcomes. Future studies should investigate how to incorporate frailty assessment in daily clinical practice as well as how to use frailty information to guide interventions to minimize post-operative complications as well as choosing alternative therapies (such as definitive radiation therapy)

oncology,radiology, nuclear medicine & medical imaging